Australia markets closed

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2300+0.1200 (+10.81%)
At close: 04:00PM EDT
1.2800 +0.05 (+4.07%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
6,665
7,338
20,948
0
6
Cost of revenue
6,698
7,380
9,163
-
-
Gross profit
-33
-42
11,785
-
-
Operating expenses
Research development
61,579
68,889
52,975
43,859
21,474
Selling general and administrative
18,545
18,963
16,180
13,418
12,354
Total operating expenses
80,124
87,852
69,155
57,277
33,828
Operating income or loss
-80,157
-87,894
-57,370
-57,277
-33,822
Total other income/expenses net
102
-78
568
-46
1,538
Income before tax
-80,031
-87,933
-56,241
-55,178
-30,055
Income from continuing operations
-80,031
-87,933
-56,241
-55,178
-30,055
Net income
-80,031
-87,933
-56,241
-55,178
-30,055
Net income available to common shareholders
-80,031
-87,933
-56,241
-55,178
-30,055
Basic EPS
-
-
-2.93
-4.60
-2.68
Diluted EPS
-
-
-2.93
-4.60
-2.68
Basic average shares
-
-
19,179
12,004
11,214
Diluted average shares
-
-
19,179
12,004
11,214
EBITDA
-
-87,604
-57,232
-57,131
-33,673